Skip to main content

Want a detailed portfolio tracker?

RMD
NYSE
$198.61

Resmed Inc (RMD)

ResMed is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea (such as CPAP devices and masks), chronic obstructive pulmonary disease (COPD), and other respiratory conditions.
Website: https://www.resmed.com
68 analysts
Buy
Target: $249.40 (+25.57%)

Market Cap

$29B

EPS 5Y CAGR

+27.03%

Profit Margin

27.9%

Forward P/E

17.01

Price Chart

Valuation
Market Cap$29B
P/E19.04
Forward P/E17.01
PEG1.15
P/S5.06
P/B4.43
Profitability
Total Revenue (TTM)$5.54B
Gross Profit (TTM)$3.44B
EBITDA$2.11B
Profit Margin27.9%
Operating Margin34.9%
EPS$10.43
Financial Health
Debt-to-Equity10.2%
Free Cash Flow Yield6.09%
Dividend Yield1.15%
Growth & Risk
EPS 5Y CAGR+27.03%
Revenue 5Y CAGR+12.37%
FCF 5Y CAGR+18.60%
Dividends 5Y CAGR+9.00%
Beta (5Y)0.60
Sharpe Ratio-0.92